These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12908815)

  • 1. Public health interventionists, penny capitalists, or sources of risk?: assessing street syringe sellers in Hartford, Connecticut.
    Stopka TJ; Singer M; Santelices C; Eiserman J
    Subst Use Misuse; 2003 Jul; 38(9):1345-77. PubMed ID: 12908815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
    Taussig JA; Weinstein B; Burris S; Jones TS
    AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syringe access for the prevention of blood borne infections among injection drug users.
    Stancliff S; Agins B; Rich JD; Burris S
    BMC Public Health; 2003 Nov; 3():37. PubMed ID: 14633286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The legality of selling or giving syringes to injection drug users.
    Burris S; Vernick JS; Ditzler A; Strathdee S
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S13-8. PubMed ID: 12489604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
    Heimer R; Clair S; Teng W; Grau LE; Khoshnood K; Singer M
    J Urban Health; 2002 Dec; 79(4):556-70. PubMed ID: 12468675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT.
    Singer M; Himmelgreen D; Weeks MR; Radda KE; Martinez R
    Med Anthropol; 1997 Dec; 18(1):107-30. PubMed ID: 9458670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve access to sterile syringes for injection drug users.
    Rich JD; Wolf FA; Macalino G
    AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High street prices of syringes correlate with strict syringe possession laws.
    Rich JD; Foisie CK; Towe CW; McKenzie M; Salas CM
    Am J Drug Alcohol Abuse; 2000 Aug; 26(3):481-7. PubMed ID: 10976670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
    Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
    Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringe availability as HIV prevention: a review of modalities.
    Coffin P
    J Urban Health; 2000 Sep; 77(3):306-30. PubMed ID: 10976607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'It's just basically a box full of disease'-navigating sterile syringe scarcity in a rural New England state.
    Pollini RA; Paquette CE; Slocum S; LeMire D
    Addiction; 2021 Jan; 116(1):107-115. PubMed ID: 32415706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
    Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.